Citizens Commission on Human Rights Ireland

03/09/2026

31/08/2026

https://www.irishtimes.com/ireland/2026/08/31/staff-dismissed-or-resigned-after-residents-were-mistreated-at-dublin-mental-health-hospital/

Mental Health Commission finds ‘critical’ areas of noncompliance at Bloomfield Hospital

26/08/2026

https://www.bbc.com/news/articles/c0kl40d3011o

There have been decades of mistreatment and mismanagement of those who seek help later in life, say experts in a new, damning report.

25/08/2026

𝗗𝗿𝘂𝗴 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀’ “𝗕𝗶𝗽𝗼𝗹𝗮𝗿” 𝗦𝗮𝗹𝗲𝘀 𝗦𝗰𝗿𝗶𝗽𝘁 𝗡𝗼𝘄 𝗣𝗹𝗮𝘆𝗶𝗻𝗴 𝗢𝘂𝘁 𝗶𝗻 𝗖𝗹𝗮𝗻𝗰𝘆 𝗧𝗿𝗶𝗮𝗹

The Lindsay Clancy trial is continuing to bring to light what psychiatry has long operated on: industry-written marketing scripts that turn drug side effects into new diagnoses and more prescriptions.

Psychiatric nurse practitioner Rebecca Jollotta testified that Lindsay Clancy’s extreme reaction to Zoloft—staying awake for 48 hours—was “unusual” and therefore evidence of possible underlying bipolar disorder. On that basis she prescribed the antipsychotic Seroquel — 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝗺𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝘀𝗰𝗿𝗶𝗽𝘁 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻𝘃𝗲𝗻𝘁𝗲𝗱 𝘁𝘄𝗼 𝗱𝗲𝗰𝗮𝗱𝗲𝘀 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘁𝗼 𝘀𝗲𝗹𝗹 𝗮𝗻𝘁𝗶𝗽𝘀𝘆𝗰𝗵𝗼𝘁𝗶𝗰𝘀 𝗮𝘀 𝗮 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝘁𝗼 𝗦𝗦𝗥𝗜 𝘀𝗶𝗱𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝘀.

That exact diagnostic switch was manufactured by pharmaceutical companies in the early 2000s. As SSRIs flooded the market, patients who became severely agitated, sleepless for days, racing with thoughts, or plunged into worsening anxiety and emotional numbness on the drugs were handed a new label: unmasked bipolar. In other words, these weren’t side effects from the SSRIs—they were an underlying “bipolar disorder” causing these issues.

𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝗹 𝗟𝗶𝗹𝗹𝘆 𝗱𝗼𝗰𝘂𝗺𝗲𝗻𝘁𝘀 𝗳𝗿𝗼𝗺 𝟮𝟬𝟬𝟬–𝟮𝟬𝟬𝟮 𝘀𝗵𝗼𝘄 𝘀𝗮𝗹𝗲𝘀 𝗿𝗲𝗽𝘀 𝘁𝗿𝗮𝗶𝗻𝗲𝗱 𝘄𝗶𝘁𝗵 𝘀𝗰𝗿𝗶𝗽𝘁𝗲𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗽𝗿𝗼𝗳𝗶𝗹𝗲𝘀—“𝗗𝗼𝗻𝗻𝗮,” “𝗔𝗻𝗱𝗿𝗲𝗮”—𝗶𝗻 𝘄𝗵𝗶𝗰𝗵 𝗮𝗻𝘅𝗶𝗲𝘁𝘆, 𝗶𝗿𝗿𝗶𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆, 𝘀𝗹𝗲𝗲𝗽𝗹𝗲𝘀𝘀𝗻𝗲𝘀𝘀, 𝗼𝗿 𝘄𝗼𝗿𝘀𝗲𝗻𝗶𝗻𝗴 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝗮𝗳𝘁𝗲𝗿 𝗮𝗻 𝗮𝗻𝘁𝗶𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗮𝗻𝘁 𝘄𝗲𝗿𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗲𝗱 𝗻𝗼𝘁 𝗮𝘀 𝘀𝗶𝗱𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝘀, 𝗯𝘂𝘁 𝗮𝘀 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗼𝗳 𝗮𝗻 𝘂𝗻𝗱𝗲𝗿𝗹𝘆𝗶𝗻𝗴 𝗯𝗶𝗽𝗼𝗹𝗮𝗿 𝗼𝗿 “𝗰𝗼𝗺𝗽𝗹𝗶𝗰𝗮𝘁𝗲𝗱 𝗺𝗼𝗼𝗱” 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝘁𝗵𝗲 𝗮𝗻𝘁𝗶𝗱𝗲𝗽𝗿𝗲𝘀𝘀𝗮𝗻𝘁 𝗵𝗮𝗱 𝘂𝗻𝗺𝗮𝘀𝗸𝗲𝗱. 𝗭𝘆𝗽𝗿𝗲𝘅𝗮 𝘄𝗮𝘀 𝘁𝗵𝗲𝗻 𝘀𝗼𝗹𝗱 𝗮𝘀 𝘁𝗵𝗲 𝗻𝗲𝗰𝗲𝘀𝘀𝗮𝗿𝘆 “𝗺𝗼𝗼𝗱 𝘀𝘁𝗮𝗯𝗶𝗹𝗶𝘇𝗲𝗿” 𝗳𝗼𝗿 𝘁𝗵𝗮𝘁 “𝘂𝗻𝗺𝗮𝘀𝗸𝗲𝗱 𝗯𝗶𝗽𝗼𝗹𝗮𝗿.”

This was a deliberate sales pitch. Representatives were instructed to present these patients as having “complicated mood” and to position Zyprexa as the solution. The Department of Justice later charged that this sales-force training and symptom-focused promotion were part of the illegal off-label marketing of Zyprexa.

The same companies that made the antidepressants then sold the next drug to “fix” what the first one caused. Lilly’s 2002 TV ad drove the message home: a high-energy woman shopping and dancing cut to her looking depressed, with the voiceover declaring people with bipolar were being treated only for depression “because depression is only half the story.” Viewers were sent to a Lilly site that steered them toward Zyprexa.

𝗜𝘁 𝘄𝗮𝘀 𝗽𝘂𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝗲𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻—𝘀𝗶𝗱𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝘀 𝗿𝗲𝗳𝗿𝗮𝗺𝗲𝗱 𝗮𝘀 𝗻𝗲𝘄 𝗱𝗶𝘀𝗲𝗮𝘀𝗲, 𝗼𝗻𝗲 𝗽𝗿𝗼𝗳𝗶𝘁𝗮𝗯𝗹𝗲 𝗰𝗹𝗮𝘀𝘀 𝗼𝗳 𝗱𝗿𝘂𝗴𝘀 𝗳𝗲𝗲𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁. In 2009 Eli Lilly paid $1.4 billion to settle charges of illegally promoting Zyprexa for off-label uses including depression and agitation. Other makers of atypical antipsychotics faced similar multimillion- and billion-dollar settlements.

Jollotta was not applying independent science. She was repeating the same marketing logic pharmaceutical companies engineered two decades earlier to turn antidepressant side effects into a pipeline for antipsychotics.

25/08/2026

19/08/2026

Dr Max Pemberton isn’t uncompassionate or especially radical, but he assembles a team of medics whose stance on the condition is clear from the off. This is a documentary that will incense and offend many

15/08/2026

It’s in the Patient Information Leaflet…..